Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18496568rdf:typepubmed:Citationlld:pubmed
pubmed-article:18496568lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:18496568lifeskim:mentionsumls-concept:C0010453lld:lifeskim
pubmed-article:18496568lifeskim:mentionsumls-concept:C0022567lld:lifeskim
pubmed-article:18496568lifeskim:mentionsumls-concept:C0623362lld:lifeskim
pubmed-article:18496568lifeskim:mentionsumls-concept:C0596138lld:lifeskim
pubmed-article:18496568lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:18496568lifeskim:mentionsumls-concept:C0441472lld:lifeskim
pubmed-article:18496568lifeskim:mentionsumls-concept:C0033414lld:lifeskim
pubmed-article:18496568lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:18496568lifeskim:mentionsumls-concept:C2752630lld:lifeskim
pubmed-article:18496568lifeskim:mentionsumls-concept:C1705206lld:lifeskim
pubmed-article:18496568lifeskim:mentionsumls-concept:C0677601lld:lifeskim
pubmed-article:18496568lifeskim:mentionsumls-concept:C0702263lld:lifeskim
pubmed-article:18496568pubmed:issue11lld:pubmed
pubmed-article:18496568pubmed:dateCreated2008-10-17lld:pubmed
pubmed-article:18496568pubmed:abstractTextCultured human keratinocytes produce matrix metalloproteinase (MMP)-2 and MMP-9. In this study, using small interfering RNA (siRNA) for MMP-2 or MMP-9, we investigated the functions of these two gelatinases in the regulation of survival by measuring growth, differentiation, apoptosis, and migration of cultured keratinocytes. MMP-2 siRNA treatment significantly decreased keratinocyte growth and migration, and stimulated apoptosis fourfold. In addition, MMP-2 siRNA caused a 70% reduction in keratin-14 (K14) and a fourfold increase in K10. In contrast, MMP-9 siRNA treatment exerted opposite effects on cell growth, apoptosis, and K10 expression. MMP-2 appears to act through the ERK MAP kinase and caspase-3 signaling pathways as evidenced by the 53% reduction in the level of phosphorylated ERK1/2 and threefold increase in phosphorylated p38 and stronger staining for active caspase-3 in response to MMP-2 siRNA. Dual fluorescent staining revealed that almost all cultured cells stained positive for MMP-2, with only a few scattered cells being positive for MMP-9. There were considerably more BrdU-positive cells following MMP-9 siRNA treatment, indicating that MMP-9 inhibited proliferation. In conclusion, MMP-2 stimulates keratinocyte survival whereas MMP-9 promotes terminal differentiation.lld:pubmed
pubmed-article:18496568pubmed:languageenglld:pubmed
pubmed-article:18496568pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18496568pubmed:citationSubsetIMlld:pubmed
pubmed-article:18496568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18496568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18496568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18496568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18496568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18496568pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18496568pubmed:statusMEDLINElld:pubmed
pubmed-article:18496568pubmed:monthNovlld:pubmed
pubmed-article:18496568pubmed:issn1523-1747lld:pubmed
pubmed-article:18496568pubmed:authorpubmed-author:JacksonChrist...lld:pubmed
pubmed-article:18496568pubmed:authorpubmed-author:XueMeilangMlld:pubmed
pubmed-article:18496568pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18496568pubmed:volume128lld:pubmed
pubmed-article:18496568pubmed:ownerNLMlld:pubmed
pubmed-article:18496568pubmed:authorsCompleteYlld:pubmed
pubmed-article:18496568pubmed:pagination2676-85lld:pubmed
pubmed-article:18496568pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:18496568pubmed:meshHeadingpubmed-meshheading:18496568...lld:pubmed
pubmed-article:18496568pubmed:meshHeadingpubmed-meshheading:18496568...lld:pubmed
pubmed-article:18496568pubmed:meshHeadingpubmed-meshheading:18496568...lld:pubmed
pubmed-article:18496568pubmed:meshHeadingpubmed-meshheading:18496568...lld:pubmed
pubmed-article:18496568pubmed:meshHeadingpubmed-meshheading:18496568...lld:pubmed
pubmed-article:18496568pubmed:meshHeadingpubmed-meshheading:18496568...lld:pubmed
pubmed-article:18496568pubmed:meshHeadingpubmed-meshheading:18496568...lld:pubmed
pubmed-article:18496568pubmed:meshHeadingpubmed-meshheading:18496568...lld:pubmed
pubmed-article:18496568pubmed:meshHeadingpubmed-meshheading:18496568...lld:pubmed
pubmed-article:18496568pubmed:meshHeadingpubmed-meshheading:18496568...lld:pubmed
pubmed-article:18496568pubmed:meshHeadingpubmed-meshheading:18496568...lld:pubmed
pubmed-article:18496568pubmed:meshHeadingpubmed-meshheading:18496568...lld:pubmed
pubmed-article:18496568pubmed:meshHeadingpubmed-meshheading:18496568...lld:pubmed
pubmed-article:18496568pubmed:year2008lld:pubmed
pubmed-article:18496568pubmed:articleTitleAutocrine actions of matrix metalloproteinase (MMP)-2 counter the effects of MMP-9 to promote survival and prevent terminal differentiation of cultured human keratinocytes.lld:pubmed
pubmed-article:18496568pubmed:affiliationSutton Arthritis Research Laboratories, Department of Rheumatology, Institute of Bone and Joint Research, The University of Sydney at Royal North Shore Hospital, St Leonards, New South Wales, Australia. mlxue@med.usyd.edu.aulld:pubmed
pubmed-article:18496568pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18496568pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:4313entrezgene:pubmedpubmed-article:18496568lld:entrezgene
entrez-gene:4318entrezgene:pubmedpubmed-article:18496568lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18496568lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18496568lld:entrezgene